Bone density in heart or lung transplant recipients--a longitudinal study.

[1]  E. M. Lewiecki,et al.  Clinician’s Guide to Prevention and Treatment of Osteoporosis , 2014, Osteoporosis International.

[2]  Zhezhen Jin,et al.  Prevention of fractures after solid organ transplantation: a meta-analysis. , 2011, The Journal of clinical endocrinology and metabolism.

[3]  Susan E. Spratt,et al.  Osteoporosis in lung transplant candidates compared to matched healthy controls , 2011, Clinical transplantation.

[4]  D. Furst,et al.  American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis , 2010, Arthritis care & research.

[5]  J. Vaquero-Barrios,et al.  Bone mineral density in lung transplant candidates. , 2010, Transplantation proceedings.

[6]  K. Boberg,et al.  Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation – a population based study , 2010, Clinical transplantation.

[7]  T. Pieber,et al.  Ibandronate Prevents Bone Loss and Reduces Vertebral Fracture Risk in Male Cardiac Transplant Patients: A Randomized Double‐Blind, Placebo‐Controlled Trial , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  P. Ebeling.  Approach to the patient with transplantation-related bone loss. , 2009, The Journal of clinical endocrinology and metabolism.

[9]  E. Shane,et al.  Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status , 2009, Osteoporosis International.

[10]  M. Vatn,et al.  Cytokines, bone turnover markers and weight change in candidates for lung transplantation. , 2008, Pulmonary pharmacology & therapeutics.

[11]  M. Leonard,et al.  Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. , 2008, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[12]  G. Yong,et al.  Strategy of aggressive steroid weaning and routine alendronate therapy to reduce bone loss after cardiac transplantation. , 2007, Transplantation proceedings.

[13]  K. Saag,et al.  Prevention and treatment of glucocorticoid-induced osteoporosis , 2007, Current osteoporosis reports.

[14]  N. Chou,et al.  Bone mineral density in long-term Chinese heart transplant recipients: a cross-sectional study. , 2006, Transplantation proceedings.

[15]  S. Hepguler,et al.  Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation , 2006, Osteoporosis International.

[16]  D. Mancini,et al.  Discontinuing Antiresorptive Therapy One Year after Cardiac Transplantation: Effect on Bone Density and Bone Turnover , 2006, Transplantation.

[17]  K. Byth,et al.  Zoledronic Acid Prevents Bone Loss after Liver Transplantation , 2006, Annals of Internal Medicine.

[18]  J. Bilezikian,et al.  Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. , 2006, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[19]  E. Shane,et al.  Osteoporosis in adult survivors of adolescent cardiac transplantation may be related to hyperparathyroidism, mild renal insufficiency, and increased bone turnover. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  E. Shane,et al.  Osteoporosis after solid organ transplantation. , 2005, The Journal of clinical endocrinology and metabolism.

[21]  J. Kanis,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report , 1994, Osteoporosis International.

[22]  G. Colice,et al.  Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases. , 2004, Chest.

[23]  H. Drexel,et al.  Relationship between various measures of bone mineral density and vertebral fractures in cardiac transplant recipients. , 2004, Swiss medical weekly.

[24]  D. Mancini,et al.  Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. , 2004, The New England journal of medicine.

[25]  R. Kotloff,et al.  Medical complications of lung transplantation , 2004, European Respiratory Journal.

[26]  J. Aranda,et al.  Resistance exercise training and alendronate reverse glucocorticoid-induced osteoporosis in heart transplant recipients. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  E. Shane,et al.  Osteoporosis after solid organ and bone marrow transplantation , 2003, Osteoporosis International.

[28]  G. Heinze,et al.  Pathogenesis of bone loss in heart transplant candidates and recipients. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  J. Kanis,et al.  Association Between Vertebral Fracture and Increased Mortality in Osteoporotic Patients , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  J. Compston.  Osteoporosis after liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  A. Berghold,et al.  Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation. , 2003, Bone.

[32]  R. Ziegler,et al.  Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation , 2003, Osteoporosis International.

[33]  P. Painter,et al.  Roles of nutrition and physical activity in musculoskeletal complications before and after liver transplantation. , 2002, AACN clinical issues.

[34]  R. Speich,et al.  Osteoporosis Before Lung Transplantation: Association with Low Body Mass Index, but Not with Underlying Disease , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[35]  G. Otto,et al.  Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study , 2001, The Lancet.

[36]  J. Eisman,et al.  Effect of Calcitriol on Bone Loss After Cardiac or Lung Transplantation , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  J. Renner,et al.  Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. , 2000, American journal of respiratory and critical care medicine.

[38]  R. Rizzoli,et al.  Bone mineral density in lung-transplant recipients before and after graft: prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[39]  A. Spira,et al.  Osteoporosis and lung transplantation: a prospective study. , 2000, Chest.

[40]  E. Shane,et al.  Bone loss and fracture after lung transplantation. , 1999, Transplantation.

[41]  E. Shane,et al.  Bone Densitometry Should Be Included in the Evaluation of Candidates for Lung Transplantation , 1999 .

[42]  P. Glendenning,et al.  High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry , 1999, Clinical endocrinology.

[43]  Jacques P. Brown,et al.  Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1998 .

[44]  R. Eastell,et al.  Mechanisms of bone loss after cardiac transplantation. , 1998, Bone.

[45]  Jacques P. Brown,et al.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. , 1998, The New England journal of medicine.

[46]  D. Mancini,et al.  Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. , 1997, The American journal of medicine.

[47]  Jacques P. Brown,et al.  Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. , 1997, The New England journal of medicine.

[48]  D. Mancini,et al.  Bone loss and turnover after cardiac transplantation. , 1997, The Journal of clinical endocrinology and metabolism.

[49]  J. Rufilanchas,et al.  Calcitonin, Etidronate, and Calcidiol Treatment in Bone Loss after Cardiac Transplantation , 1997, Calcified Tissue International.

[50]  Michael C. Nevitt,et al.  Mortality Following Fractures in Older Women: The Study of Osteoporotic Fractures , 1996 .

[51]  T. Egan,et al.  Severe osteoporosis before and after lung transplantation. , 1996, Chest.

[52]  D. Mancini,et al.  Fracture after cardiac transplantation: a prospective longitudinal study. , 1996, The Journal of clinical endocrinology and metabolism.

[53]  J. Eisman,et al.  Bone mineral loss and recovery after cardiac transplantation , 1995, The Lancet.

[54]  J. Casez,et al.  Changes in bone mass early after kidney transplantation , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[55]  C. Libanati,et al.  Prevention and treatment of glucocorticoid-induced osteoporosis. A pathogenetic perspective. , 1992, Chest.

[56]  G. McCaughan,et al.  Bone loss after liver transplantation , 1991, Hepatology.

[57]  E. Dickson,et al.  Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis , 1991, Hepatology.